ALLO
Allogene Therapeutics, Inc.NASDAQStock$2.26-0.06 (-2.60%)Mkt Cap 550.8MP/E —Div Yield —Beta 0.54Vol 5.7MAvg Vol 21.1M
52W$0.95
$3.06
ETFs That Hold ALLO (Allogene Therapeutics, Inc.)
1M
+1.35%
3M
+47.06%
6M
+84.43%
YTD
+66.67%
1Y
+43.31%
3Y
-58.56%
5Y
-93.55%
ETFs That Hold ALLO
Allogene Therapeutics, Inc. is held by 44 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 3 of 3
Frequently Asked Questions
How many ETFs hold ALLO?
Allogene Therapeutics, Inc. (ALLO) is held by 44 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds ALLO?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $8.97B in AUM holds 0.16% of its portfolio in ALLO, representing $13.7M in market value.
What percentage of CNCR is ALLO?
ALLO makes up 3.29% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is ALLO in the S&P 500?
ALLO is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.